Showing results (111-120 of 242) with videos related to
Sort By:
Pageof 25
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 24, 2009
Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptorsAna M Catafau, Graham E Searle, Santiago Bullich, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2019
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-JAyla Mansur, Eugenii A Rabiner, Robert A Comley, et al.Neuroimage|January 20, 2010
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analysesPhilipp T Meyer, Zubin Bhagwagar, Philip J Cowen, et al.Cancer Research|October 18, 2002
Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignanciesPaula Wells, Roger N Gunn, Malcolm Alison, et al.Inflammatory Bowel Diseases|October 19, 2016
Role of 18F-fluorodeoxyglucose Positron Emission Tomography in the Monitoring of Inflammatory Activity in Crohn's DiseaseEvangelos A Russo, Sameer Khan, Ryan Janisch, et al.Journal of Clinical Psychopharmacology|October 25, 2011
Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorderEmiliangelo Ratti, Kevin Bellew, Paolo Bettica, et al.British Journal of Clinical Pharmacology|January 13, 2011
Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy menMarieke Liem-Moolenaar, Mandana Rad, Stefano Zamuner, et al.Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.Parkinsonism & Related Disorders|March 3, 2019
The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseHeather Wilson, Gennaro Pagano, Flavia Niccolini, et al.Scientific Reports|October 22, 2020
Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromesAlberto A Toffano, Giacomo Chiarot, Stefano Zamuner, et al.Pageof 25